Mapping Actuarial Criteria for Parkinson's Disease-Mild Cognitive Impairment onto Data-Driven Cognitive Phenotypes

Lauren E Kenney1,2, Adrianna M Ratajska1,2, Francesca V Lopez1,2

  • 1Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32603, USA.

Brain Sciences
|January 21, 2022
PubMed

Insights

The optimal cutoff for classifying mild cognitive impairment in Parkinson's disease (PD-MCI) is -1.5 SD. This method accurately identifies PD-MCI subtypes and predicts dementia risk.

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Mild cognitive impairment in Parkinson's disease (PD-MCI) has variable prevalence, limiting its use in predicting dementia risk.
  • Inconsistent diagnostic criteria, specifically the operationalization of normative cutoffs, contribute to this variability.

Purpose of the Study:

  • To identify the optimal cutoff score for classifying PD-MCI.
  • To compare different cutoffs (-1, -1.5, -2 SD) against data-driven cognitive phenotypes in Parkinson's disease.

Main Methods:

  • 494 participants with idiopathic Parkinson's disease underwent neuropsychological testing.
  • Cluster analyses (K-means, Hierarchical) identified cognitive phenotypes.
  • PD-MCI was assessed using separate cutoffs (-1, -1.5, -2 SD) on at least two tests within a domain.

Main Results:

  • Cluster analysis revealed three distinct cognitive phenotypes: Cognitively Average, Low Executive Function (EF), and Prominent EF/Memory Impairment.
  • The -1.5 SD cutoff demonstrated the highest accuracy (87.9%) in classifying PD-MCI and best aligned with the identified cognitive phenotypes.
  • This cutoff showed superior validity in identifying cognitive profiles associated with increased dementia risk.

Conclusions:

  • The -1.5 SD cutoff is recommended for classifying PD-MCI due to its optimal performance and alignment with empirical cognitive profiles.
  • Comparing empirical and actuarial approaches is crucial for establishing the concurrent validity of cognitive impairment diagnoses in Parkinson's disease.
  • Standardizing diagnostic criteria for PD-MCI enhances its predictive utility for dementia risk.